Latest News

Stay up to date with the latest stock market news from around the world. From breaking news written by our finance analysts to event-driven market news on a global scale.

NYSE:EL
NYSE:ELPersonal Products

Is Estée Lauder (EL) Finally Turning A Corner After Recent Share Price Rebound

If you are wondering whether Estée Lauder Companies at around US$82.85 is giving you fair value, a discount, or an expensive ticket to future expectations, this breakdown is for you. The stock has returned 7.5% over the last week and 19.9% over the last month, while the 1 year return is 43.8%. However, the 3 year and 5 year returns are 56.5% and 69.8% declines, which raises real questions about how to read the current price. Recent coverage has focused on how the share price has moved...
NYSE:APLE
NYSE:APLEHotel and Resort REITs

Apple Hospitality REIT (APLE) Q1 FFO Stability Tests Bearish Margin Narratives

Apple Hospitality REIT’s Q1 2026 Earnings Snapshot Apple Hospitality REIT (APLE) opened 2026 with Q1 Funds From Operations of US$76.5 million and trailing 12 month net profit margins of 12.4%, while the stock trades around US$13.61. Over the past reported quarters, revenue has moved from US$333.0 million in Q4 2024 to US$327.7 million in Q1 2025 and US$326.4 million in Q4 2025, alongside basic EPS readings between US$0.12 and US$0.27 and trailing 12 month FFO in the US$359.2 million range...
NasdaqGM:LGND
NasdaqGM:LGNDPharmaceuticals

Did Higher 2026 Guidance and XOMA Deal Just Shift Ligand Pharmaceuticals' (LGND) Investment Narrative?

Ligand Pharmaceuticals recently raised its 2026 revenue guidance to a range of US$270 million to US$310 million and discussed its planned acquisition of XOMA Royalty, while also participating in several investor conferences, including the H.C. Wainwright Royalty Company Virtual Conference on May 6, 2026. This combination of higher guidance, an expanded royalty portfolio through the proposed XOMA Royalty acquisition, and active investor outreach could reshape how investors view Ligand’s...
NYSE:PGR
NYSE:PGRInsurance

Progressive Expands UpPayment Program As Investors Weigh Homeowners Growth Potential

Progressive (NYSE:PGR) is expanding its UpPayment program to offer larger down payment assistance for first-time homebuyers. The initiative aims to support hundreds of eligible applicants as part of a broader push to make homeownership more accessible. The program expansion is positioned within Progressive's wider homeownership and community engagement efforts. Progressive, trading at around $197.74, is drawing attention not for its share price moves but for this new push into direct...
NasdaqCM:SATL
NasdaqCM:SATLAerospace & Defense

Satellogic Hires Industry Veterans As Sovereign Geo-Intelligence Strategy Meets Market Hype

Satellogic (NasdaqCM:SATL) has expanded its global sales organization with three senior industry veterans focused on sovereign geospatial intelligence customers. The hires are aimed at deepening relationships with defense and intelligence agencies and supporting the company's wider commercial push. For investors tracking NasdaqCM:SATL, these leadership additions come after the previously announced $12 million satellite transfer agreement and at a time when the stock is trading around $7.0...
NYSE:VICI
NYSE:VICISpecialized REITs

VICI Expands Casino And Experiential Portfolio While Shares Screen Undervalued

VICI Properties (NYSE:VICI) completed a $1.2b sale leaseback acquisition of seven casinos from Golden Entertainment. The deal adds multiple Las Vegas area properties to VICI’s portfolio, expanding its role as a landlord in gaming real estate. Golden used transaction proceeds to address existing debt, while VICI secured new long term rental income streams. Alongside this transaction, VICI has announced new investments and an expansion into alternative experiential assets. For investors...
SEHK:697
SEHK:697Real Estate

Asian Market Insights With 3 Stocks That May Be Trading Below Estimated Value

As central banks in Japan and China maintain steady interest rates amidst global uncertainties, the Asian markets are navigating a complex landscape marked by geopolitical tensions and evolving economic policies. In this environment, identifying stocks that may be trading below their estimated value can offer strategic opportunities for investors seeking to capitalize on potential market inefficiencies.
SEHK:8439
SEHK:8439Capital Markets

Asian Penny Stocks: 3 Picks With Market Caps Under US$4B

The Asian markets have been navigating a complex landscape, with central banks maintaining steady interest rates amidst geopolitical tensions and fluctuating oil prices. In this context, penny stocks—though an older term—remain relevant for investors seeking potential growth in smaller or newer companies. When these stocks are supported by strong financials, they can offer unique opportunities for value and growth that larger firms might overlook.
SZSE:000921
SZSE:000921Consumer Durables

Asian Dividend Stocks To Consider In May 2026

As global markets navigate a complex landscape marked by geopolitical tensions and fluctuating oil prices, Asian equities have shown resilience, with China's stable outlook and Japan's evolving monetary policies capturing attention. In this environment, dividend stocks in Asia can offer investors a combination of income stability and potential growth, making them an attractive consideration for those seeking to balance risk amid economic uncertainties.
NasdaqGS:TEAM
NasdaqGS:TEAMSoftware

Is It Time To Revisit Atlassian (TEAM) After Recent 32% Weekly Price Surge?

Wondering whether Atlassian at around US$92.35 is priced attractively or still looks expensive? This article breaks down what that current market price might imply about the stock's value. The share price has moved sharply in the short term, with a 32.5% return over the last 7 days and 35.2% over the last 30 days, while longer term returns sit at a 40.3% decline year to date and a 55.6% decline over the last year. Recent coverage has focused on Atlassian as a key software platform provider,...
NYSE:RACE
NYSE:RACEAuto

Is Ferrari (NYSE:RACE) Now A Luxury Bargain After A 30% Share Price Slide?

Wondering if Ferrari stock at around US$325 is a premium worth paying or a potential bargain hiding in plain sight? This article walks through the key numbers so you can judge the value for yourself. The stock is down about 5% over the last 7 days, 4.3% over the last month, 12.5% year to date and 30.6% over the past year. Over a longer horizon, the 3 year and 5 year returns sit at 13.5% and 71.1% respectively. Recent coverage has focused on Ferrari as a high end auto stock, with attention on...
NasdaqGS:HSIC
NasdaqGS:HSICHealthcare

Henry Schein (HSIC) Margins Hold Near 3% And Keep Profitability Debate Alive Heading Into Q1

Henry Schein (HSIC) sets the stage with steady top line and consistent earnings Henry Schein (HSIC) opened Q1 2026 earnings season on the back of Q4 2025 revenue of about $3.4 billion and basic EPS of $0.86, with trailing twelve month figures at $13.2 billion of revenue and EPS of $3.29 helping frame the latest print. Over the past year, revenue has moved from $12.7 billion to $13.2 billion while trailing EPS shifted from $3.08 to $3.29, giving you a clearer sense of how the top line and per...
NasdaqGS:YORW
NasdaqGS:YORWWater Utilities

York Water (YORW) Margin Slippage Tests Premium P/E Growth Narrative

York Water’s latest earnings snapshot York Water (YORW) has just posted another quarter of steady utility earnings, with Q4 2025 revenue at US$19.5 million and basic EPS of US$0.36, supported by trailing 12 month revenue of US$77.5 million and EPS of US$1.39. Over recent quarters the company has seen revenue range between US$18.5 million and US$20.4 million, with quarterly EPS between US$0.25 and US$0.43. The trailing net profit margin sits at 25.9% compared with 27.1% a year earlier, which...
NYSE:XOM
NYSE:XOMOil and Gas

Exxon Mobil (XOM) Margin Decline Puts Premium P/E And Bullish Narratives Under Scrutiny

Exxon Mobil (XOM) opened 2026 with first quarter revenue of US$83.2b, basic EPS of US$1.00, and net income of US$4.2b, setting the tone for how the market will judge its latest move in profitability. Over the past year, revenue on a trailing basis has held around US$326.0b while trailing EPS has been about US$5.94, giving investors a clearer sense of how the current quarter fits into the recent earnings run rate. With the stock trading at US$154.88 and trailing net margin at 7.8% versus 9.8%...
TSX:REI.UN
TSX:REI.UNRetail REITs

RioCan REIT Q1 FFO Per Unit Drop Tests Bullish Cash Flow Narratives

RioCan Real Estate Investment Trust (TSX:REI.UN) opened 2026 with Q1 Funds From Operations of $117.78 million and FFO per share of $0.40, setting the tone for how income focused investors will read the latest numbers. Over recent quarters the trust has seen FFO move between $134.38 million and $145.56 million, with FFO per share ranging from $0.45 to $0.49. This gives a clear view of how cash based performance has tracked heading into this update. With trailing net profit margins now at 5.6%...
NasdaqGS:PLMR
NasdaqGS:PLMRInsurance

Is Palomar Holdings (PLMR) Attractive After Recent Share Price Pullback?

Wondering whether Palomar Holdings at around US$111.73 is priced for opportunity or risk? This article breaks the stock down so you can judge the value for yourself. The share price has seen a 12.1% pullback over the last 7 days and is down 15.2% year to date, after a 28.5% decline over the past year and a 128.2% gain across the last 3 years. Recent headlines around Palomar have focused on its position within the insurance sector and how investors are reassessing risk for specialty insurers...
NYSE:JLL
NYSE:JLLReal Estate

A Look At Jones Lang LaSalle (JLL) Valuation After Strong First Quarter Sales And Net Income Growth

Jones Lang LaSalle (JLL) opened its latest update with a first quarter earnings release showing higher sales and net income than a year earlier, a combination that helped frame the stock’s recent move. See our latest analysis for Jones Lang LaSalle. The strong first quarter update and the recent completion of a sizeable buyback program, which retired 15.66% of shares over several years, come as the stock trades at US$318.13. Despite a 6.86% 7 day share price decline and a 5.27% year to date...
NasdaqGM:STIM
NasdaqGM:STIMMedical Equipment

Neuronetics (STIM) Margin Compression Reinforces Bearish Clinic Mix Narrative

Neuronetics (STIM) has just put fresh numbers on the table for Q1 2026, and recent filings show quarterly revenue at US$41.8 million in Q4 2025 with a basic EPS loss of US$0.10, alongside trailing twelve month revenue of US$149.2 million and a basic EPS loss of US$0.59. Over recent quarters, the company has seen revenue move from US$18.5 million in Q3 2024 to US$22.5 million in Q4 2024 and then to US$42.8 million in Q4 2025, while quarterly basic EPS losses shifted from US$0.44 to US$0.35 and...
NYSE:BAX
NYSE:BAXMedical Equipment

Assessing Baxter International’s Valuation After Earnings Beat And Guidance Reaffirmation

Why Baxter International (BAX) is back on investors’ radar Baxter International (BAX) moved back into focus after first quarter results topped revenue and non GAAP profit expectations, management reiterated full year earnings guidance, and analysts responded with more constructive commentary on the stock. See our latest analysis for Baxter International. The better than expected first quarter and reaffirmed full year earnings guidance came after a tough stretch for shareholders, with a 90 day...